The identification and characterization of TPA OMPs has been challenging due to the inability to genetically manipulate and cultivate TPA in vitro (until recently) (34), and the fragility of its OM, which generated a strong controversy in some studies. The gene discussed is PLAT; the disease is ocular melanoma.